An introduction to health technology assessment and health economic evaluation: an online self-learning course

Author:

Wiethoff IsabellORCID,Evers Silvia M. A. A.,Michels Michelle,Hiligsmann Mickaël

Abstract

AbstractCardiovascular diseases impose an enormous burden on patients and society. New health technologies promise to lower this burden; however, novel treatments often come at a high cost. In the Netherlands, health technology assessment (HTA) is increasingly being used to inform policy bodies about the optimal distribution of scarce healthcare resources and to guide decision-making about financing and reimbursement. In particular, economic evaluations, as one pillar of HTA, are frequently used to compare the costs and effects of different interventions. This paper aims to define HTA and its relevance to healthcare policy as well as providing a comprehensive overview of the methodology of economic evaluations targeting health professionals and researchers with limited prior knowledge of this subject. Accordingly, different types of economic evaluations are introduced, together with their respective costs and outcomes. Further, the results of economic evaluations are explained, along with techniques for performing them and methods for coping with uncertainty. In addition to this paper-based learning format, each chapter is complemented by a video lecture with further information and practical examples, helping to better understand and analyse health economic studies.

Funder

Hartstichting

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. de Boer AR, van Dis I, Visseren FLJ, Vaartjes I, Bots ML. Hart- en vaatziekten in Nederland 2019, cijfers over incidentie, prevalentie, ziekte en sterfte. Den Haag: Hartstichting; 2019.

2. Leening MJ, Siregar S, Vaartjes I, et al. Heart disease in the Netherlands: a quantitative update. Neth Heart J. 2014;22:3–10.

3. Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Hart- en vaatziekten 2022. https://www.vzinfo.nl/hart-en-vaatziekten. Accessed 6 Oct 2022.

4. Raina A, Kanwar M. New drugs and devices in the pipeline for heart failure with reduced ejection fraction versus heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2014;11:374–81.

5. Lee RT, Walsh K. The future of cardiovascular regenerative medicine. Circulation. 2016;133:2618–25.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3